Case Studies

Market Opportunities Among Diseases Treated With Immunosuppressants & Steroids

Approach: Data was collected from a comprehensive range of authoritative sources, including treatment guidelines, clinical trials, systematic reviews, meta-analyses, real-world evidence articles, widely respected medical websites (such as Medscape, Medline, and UpToDate), PubMed, and general searches. Approximately 200 autoimmune indications, with potential for immunosuppressant use and including both conditions with and without FDA-approved drugs, were […]

Read More →

Potential In-licensing Product Candidates

Approach: The process begins by screening products from multiple regulatory and scientific databases (KEGG, PMDA, EMA, FDA) using defined inclusion and exclusion criteria. Selection focuses on products approved in the US or EU between 2016 and 2024, recognized as new molecular or biologic entities not yet approved in Japan, yielding an initial list of 170 […]

Read More →

Market Share Tracking Of Medical Equipment Using Import Data

Approach: The raw data is initially received in CSV or Excel formats and requires thorough cleaning before it is suitable for analysis. The cleaning process involves identifying and segregating relevant from non-relevant records using specific keywords related to the products of interest. Each import entry is accurately tagged to the corresponding companies and products, with […]

Read More →

Holter Ecg Device – Regulatory Requirements And Competitor Data Analysis

Approach: The methodology for analyzing the Holter ECG market followed a structured approach focusing on three key areas. Firstly, a comprehensive regulatory analysis was performed, examining device classification, approval processes, quality management systems, and specific regional requirements for Holter ECG devices. Secondly, major market players were identified and profiled, highlighting their headquarters, product portfolios, and […]

Read More →